ASPN and gastric cancer: In gastric cancer, asporin, which is upregulated at various stages of gastric cancer, has been suggested to suppress the cancer cell apoptosis and promote cell proliferation by activating LEF1‐mediated gene transcription independently of β‐catenin [25].